DENTSPLY SIRONA (XRAY) Stock Forecast, Price Target & Predictions
XRAY Stock Forecast
DENTSPLY SIRONA stock forecast is as follows: an average price target of $40.00 (represents a 52.21% upside from XRAY’s last price of $26.28) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
XRAY Price Target
The average price target for DENTSPLY SIRONA (XRAY) is $40.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $52.00 to $28.00. This represents a potential 52.21% upside from XRAY's last price of $26.28.
XRAY Analyst Ratings
According to 5 Wall Street analysts, DENTSPLY SIRONA's rating consensus is 'Buy'. The analyst rating breakdown for XRAY stock is 0 'Strong Buy' (0.00%), 3 'Buy' (60.00%), 2 'Hold' (40.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
DENTSPLY SIRONA Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $31.00 | $26.36 | 17.60% | 17.96% |
| Jul 18, 2024 | Jonathan Block | Stifel Nicolaus | $28.00 | $27.54 | 1.67% | 6.54% |
| May 03, 2024 | Jason Bednar | Piper Sandler | $32.00 | $28.13 | 13.76% | 21.77% |
| Nov 16, 2023 | David Saxon | Needham | $35.00 | $29.61 | 18.18% | 33.18% |
| Jun 01, 2022 | Kevin Caliendo | UBS | $47.00 | $39.04 | 20.39% | 78.84% |
| Apr 22, 2022 | - | H.C. Wainwright | $48.00 | $42.09 | 14.04% | 82.65% |
| Apr 21, 2022 | - | Goldman Sachs | $47.00 | $42.89 | 9.58% | 78.84% |
| Apr 20, 2022 | - | Morgan Stanley | $52.00 | $42.89 | 21.24% | 97.87% |
| Apr 20, 2022 | - | Piper Sandler | $46.00 | $42.20 | 9.00% | 75.04% |
| Apr 19, 2022 | Jeffrey Johnson | Robert W. Baird | $48.00 | $42.63 | 12.60% | 82.65% |
The latest DENTSPLY SIRONA stock forecast, released on Jul 22, 2024 by Jeff Johnson from Robert W. Baird, set a price target of $31.00, which represents a 17.60% increase from the stock price at the time of the forecast ($26.36), and a 17.96% increase from XRAY last price ($26.28).
DENTSPLY SIRONA Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 4 |
| Avg Price Target | - | $29.50 | $31.50 |
| Last Closing Price | $26.28 | $26.28 | $26.28 |
| Upside/Downside | -100.00% | 12.25% | 19.86% |
In the current month, the average price target of DENTSPLY SIRONA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to DENTSPLY SIRONA's last price of $26.28. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 20, 2024 | Evercore Partners | Underperform | Underperform | Hold |
| Aug 20, 2024 | Needham | Buy | Buy | Hold |
| Jul 18, 2024 | Piper Sandler | Buy | Buy | Hold |
| Jul 18, 2024 | Needham | Underperform | Underperform | Hold |
| Jun 25, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 06, 2024 | Piper Sandler | Buy | Buy | Hold |
| May 03, 2024 | Piper Sandler | Neutral | Neutral | Hold |
| Apr 18, 2024 | Leerink Partners | Underperform | Underperform | Hold |
| Apr 18, 2024 | Needham | Buy | Buy | Hold |
| Feb 29, 2024 | Piper Sandler | Buy | Buy | Hold |
DENTSPLY SIRONA's last stock rating was published by Evercore Partners on Aug 20, 2024. The company gave XRAY a "Underperform" rating, the same as its previous rate.
DENTSPLY SIRONA Financial Forecast
DENTSPLY SIRONA Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $947.00M | $1.03B | $978.00M | $983.00M | $947.00M | - | $965.00M | $1.09B | $1.07B | $1.07B | $1.03B | $1.08B | $894.80M |
| Avg Forecast | $1.01B | $1.01B | $1.01B | $1.01B | $1.07B | $998.76M | $1.05B | $1.01B | $1.04B | $965.06M | $1.01B | $977.31M | $1.01B | $938.18M | $993.61M | $969.45M | $971.51M | $975.21M | $998.98M | $937.70M | $941.92M | $1.01B | $1.01B | $991.01M | $1.13B | $1.03B | $1.01B | $947.57M | $997.38M | $839.02M |
| High Forecast | $1.03B | $1.02B | $1.02B | $1.02B | $1.08B | $1.01B | $1.06B | $1.02B | $1.05B | $976.19M | $1.03B | $988.59M | $1.02B | $948.44M | $1.01B | $980.64M | $994.25M | $986.46M | $1.01B | $948.52M | $952.78M | $1.02B | $1.01B | $997.66M | $1.14B | $1.03B | $1.02B | $953.92M | $1.00B | $844.65M |
| Low Forecast | $1.00B | $1.00B | $999.15M | $996.97M | $1.05B | $987.96M | $1.04B | $1.00B | $1.03B | $954.63M | $1.00B | $966.75M | $994.37M | $927.49M | $982.87M | $958.98M | $951.41M | $964.67M | $988.18M | $927.57M | $931.74M | $996.98M | $1.01B | $974.00M | $1.11B | $1.01B | $995.00M | $931.30M | $980.26M | $824.62M |
| # Analysts | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 9 | 7 | 5 | 5 | 9 | 11 | 10 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.97% | 1.03% | 1.04% | 1.04% | 0.94% | - | 0.97% | 0.96% | 1.04% | 1.05% | 1.08% | 1.09% | 1.07% |
DENTSPLY SIRONA's average Quarter revenue forecast for Dec 23 based on 10 analysts is $971.51M, with a low forecast of $951.41M, and a high forecast of $994.25M. XRAY's average Quarter revenue forecast represents a 2.59% increase compared to the company's last Quarter revenue of $947.00M (Sep 23).
DENTSPLY SIRONA EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 9 | 7 | 5 | 5 | 9 | 11 | 10 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $77.00M | $158.00M | $138.00M | $34.00M | $142.00M | - | $182.00M | $235.00M | $239.00M | $243.00M | $254.00M | $226.90M | $188.00M |
| Avg Forecast | $203.79M | $203.34M | $202.90M | $202.46M | $214.07M | $200.63M | $210.95M | $203.40M | $208.32M | $193.86M | $203.75M | $196.32M | $201.93M | $188.46M | $199.60M | $207.93M | $195.16M | $195.90M | $200.67M | $189.02M | $189.21M | $247.62M | $203.27M | $171.84M | $243.92M | $225.11M | $216.03M | $179.29M | $200.35M | $122.12M |
| High Forecast | $206.14M | $205.69M | $205.24M | $204.79M | $216.54M | $202.94M | $213.38M | $205.75M | $210.73M | $196.10M | $206.10M | $198.59M | $204.26M | $190.52M | $201.90M | $249.51M | $199.72M | $198.16M | $202.99M | $226.83M | $191.40M | $297.14M | $203.27M | $206.21M | $292.71M | $270.13M | $259.24M | $215.14M | $201.70M | $146.54M |
| Low Forecast | $201.58M | $201.15M | $200.71M | $200.27M | $211.76M | $198.46M | $208.67M | $201.20M | $206.07M | $191.77M | $201.54M | $194.20M | $199.75M | $186.31M | $197.44M | $166.34M | $191.12M | $193.78M | $198.51M | $151.22M | $187.17M | $198.09M | $203.27M | $137.47M | $195.14M | $180.09M | $172.82M | $143.43M | $196.91M | $97.70M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.39% | 0.79% | 0.73% | 0.18% | 0.57% | - | 1.06% | 0.96% | 1.06% | 1.12% | 1.42% | 1.13% | 1.54% |
10 analysts predict XRAY's average Quarter EBITDA for Dec 23 to be $195.16M, with a high of $199.72M and a low of $191.12M. This is 153.45% upper than DENTSPLY SIRONA's previous annual EBITDA (Sep 23) of $77.00M.
DENTSPLY SIRONA Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 9 | 7 | 5 | 5 | 9 | 11 | 10 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-266.00M | $86.00M | $-23.00M | $-15.00M | $-1.08B | - | $65.00M | $102.00M | $103.00M | $99.00M | $117.00M | $98.50M | $53.80M |
| Avg Forecast | $118.58M | $96.59M | $101.38M | $88.86M | $153.69M | $129.03M | $136.69M | $123.22M | $134.84M | $113.50M | $116.76M | $104.85M | $123.14M | $97.26M | $102.04M | $75.50M | $89.03M | $99.48M | $88.79M | $68.64M | $66.91M | $108.07M | $114.31M | $62.40M | $105.87M | $98.25M | $89.86M | $83.57M | $135.28M | $38.90M |
| High Forecast | $120.35M | $98.04M | $102.90M | $90.19M | $156.00M | $130.97M | $138.74M | $125.07M | $136.86M | $115.20M | $118.51M | $106.42M | $124.98M | $101.40M | $103.57M | $90.60M | $95.24M | $100.97M | $90.12M | $82.37M | $67.91M | $129.68M | $114.31M | $74.88M | $127.05M | $117.90M | $107.83M | $100.29M | $136.46M | $46.68M |
| Low Forecast | $116.91M | $95.23M | $99.95M | $87.61M | $151.54M | $127.22M | $134.77M | $121.49M | $132.95M | $111.91M | $115.12M | $103.38M | $121.40M | $95.19M | $100.61M | $60.40M | $86.96M | $98.08M | $87.54M | $54.91M | $65.97M | $86.46M | $114.31M | $49.92M | $84.70M | $78.60M | $71.89M | $66.86M | $132.26M | $31.12M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.67% | 0.97% | -0.34% | -0.22% | -9.97% | - | 1.04% | 0.96% | 1.05% | 1.10% | 1.40% | 0.73% | 1.38% |
DENTSPLY SIRONA's average Quarter net income forecast for Sep 23 is $99.48M, with a range of $98.08M to $100.97M. XRAY's average Quarter net income forecast represents a 15.67% increase compared to the company's last Quarter net income of $86.00M (Jun 23).
DENTSPLY SIRONA SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 9 | 7 | 5 | 5 | 9 | 11 | 10 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $372.00M | $416.00M | $416.00M | $402.00M | $401.00M | - | $374.00M | $374.00M | $394.00M | $398.00M | $385.00M | $420.50M | $341.90M |
| Avg Forecast | $412.52M | $411.63M | $410.73M | $409.84M | $433.34M | $406.13M | $427.02M | $411.75M | $421.71M | $392.43M | $412.44M | $397.41M | $408.77M | $381.50M | $404.04M | $434.44M | $395.05M | $396.56M | $406.22M | $394.94M | $383.02M | $413.40M | $411.47M | $359.04M | $388.20M | $375.82M | $361.26M | $275.00M | $405.57M | $247.20M |
| High Forecast | $417.28M | $416.37M | $415.47M | $414.56M | $438.34M | $410.82M | $431.94M | $416.49M | $426.57M | $396.96M | $417.20M | $402.00M | $413.48M | $385.67M | $408.70M | $521.33M | $404.30M | $401.13M | $410.91M | $473.93M | $387.44M | $496.08M | $411.47M | $430.85M | $465.84M | $450.98M | $433.51M | $330.00M | $408.29M | $296.65M |
| Low Forecast | $408.07M | $407.18M | $406.29M | $405.41M | $428.66M | $401.74M | $422.40M | $407.30M | $417.15M | $388.19M | $407.98M | $393.12M | $404.35M | $377.15M | $399.67M | $347.55M | $386.88M | $392.27M | $401.83M | $315.96M | $378.88M | $330.72M | $411.47M | $287.23M | $310.56M | $300.65M | $289.01M | $220.00M | $398.61M | $197.76M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.94% | 1.02% | 1.05% | 1.05% | 0.97% | - | 1.04% | 0.96% | 1.05% | 1.10% | 1.40% | 1.04% | 1.38% |
DENTSPLY SIRONA's average Quarter SG&A projection for Dec 23 is $395.05M, based on 10 Wall Street analysts, with a range of $386.88M to $404.30M. The forecast indicates a 6.20% rise compared to XRAY last annual SG&A of $372.00M (Sep 23).
DENTSPLY SIRONA EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 9 | 10 | 9 | 9 | 10 | 9 | 9 | 9 | 8 | 8 | 4 | 9 | 7 | 5 | 5 | 9 | 11 | 10 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-1.26 | $0.41 | $-0.11 | $-0.07 | $-5.01 | - | $0.32 | $0.47 | $0.47 | $0.45 | $0.53 | $0.45 | $0.25 |
| Avg Forecast | $0.58 | $0.47 | $0.49 | $0.43 | $0.75 | $0.63 | $0.66 | $0.60 | $0.66 | $0.55 | $0.57 | $0.51 | $0.60 | $0.47 | $0.50 | $0.42 | $0.43 | $0.48 | $0.43 | $0.34 | $0.33 | $0.52 | $0.55 | $0.56 | $0.79 | $0.65 | $0.66 | $0.57 | $0.64 | $0.32 |
| High Forecast | $0.59 | $0.48 | $0.50 | $0.44 | $0.76 | $0.64 | $0.67 | $0.61 | $0.67 | $0.56 | $0.58 | $0.52 | $0.61 | $0.49 | $0.50 | $0.42 | $0.46 | $0.49 | $0.44 | $0.34 | $0.33 | $0.53 | $0.55 | $0.57 | $0.79 | $0.65 | $0.67 | $0.57 | $0.65 | $0.32 |
| Low Forecast | $0.57 | $0.46 | $0.49 | $0.43 | $0.74 | $0.62 | $0.66 | $0.59 | $0.65 | $0.54 | $0.56 | $0.50 | $0.59 | $0.46 | $0.49 | $0.41 | $0.42 | $0.48 | $0.43 | $0.33 | $0.32 | $0.52 | $0.55 | $0.55 | $0.77 | $0.63 | $0.65 | $0.56 | $0.63 | $0.31 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -2.60% | 0.95% | -0.32% | -0.21% | -9.59% | - | 0.57% | 0.60% | 0.72% | 0.68% | 0.93% | 0.70% | 0.79% |
According to 9 Wall Street analysts, DENTSPLY SIRONA's projected average Quarter EPS for Sep 23 is $0.48, with a low estimate of $0.48 and a high estimate of $0.49. This represents a 18.01% increase compared to XRAY previous annual EPS of $0.41 (Jun 23).
DENTSPLY SIRONA Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $110.53 | $298.00 | 169.61% | Buy |
| ANGO | AngioDynamics | $7.64 | $17.00 | 122.51% | Buy |
| XRAY | DENTSPLY SIRONA | $26.28 | $40.00 | 52.21% | Buy |
| HAE | Haemonetics | $76.09 | $104.33 | 37.11% | Buy |
| TFX | Teleflex | $246.05 | $304.09 | 23.59% | Buy |
| BDX | Becton, Dickinson and Company | $234.18 | $280.55 | 19.80% | Buy |
| WST | West Pharmaceutical Services | $300.67 | $345.33 | 14.85% | Buy |
| HOLX | Hologic | $81.15 | $78.92 | -2.75% | Buy |
| MMSI | Merit Medical Systems | $96.16 | $93.38 | -2.89% | Buy |
| ALC | Alcon | $98.50 | $93.34 | -5.24% | Buy |
| RMD | ResMed | $248.93 | $209.33 | -15.91% | Hold |
| ICUI | ICU Medical | $179.00 | $135.00 | -24.58% | Buy |
XRAY Forecast FAQ
Is DENTSPLY SIRONA a good buy?
Yes, according to 5 Wall Street analysts, DENTSPLY SIRONA (XRAY) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 60.00% of XRAY's total ratings.
What is XRAY's price target?
DENTSPLY SIRONA (XRAY) average price target is $40 with a range of $28 to $52, implying a 52.21% from its last price of $26.28. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will DENTSPLY SIRONA stock go up soon?
According to Wall Street analysts' prediction for XRAY stock, the company can go up by 52.21% (from the last price of $26.28 to the average price target of $40), up by 97.87% based on the highest stock price target, and up by 6.54% based on the lowest stock price target.
Can DENTSPLY SIRONA stock reach $40?
XRAY's highest twelve months analyst stock price target of $52 supports the claim that DENTSPLY SIRONA can reach $40 in the near future.
What are DENTSPLY SIRONA's analysts' financial forecasts?
DENTSPLY SIRONA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $4.13B (high $4.17B, low $4.08B), average EBITDA is $829.05M (high $838.61M, low $820.09M), average net income is $542.64M (high $550.78M, low $535.02M), average SG&A $1.68B (high $1.7B, low $1.66B), and average EPS is $2.64 (high $2.68, low $2.6). XRAY's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $4.04B (high $4.09B, low $4B), average EBITDA is $812.49M (high $821.86M, low $803.71M), average net income is $405.41M (high $411.49M, low $399.71M), average SG&A $1.64B (high $1.66B, low $1.63B), and average EPS is $1.97 (high $2, low $1.94).
Did the XRAY's actual financial results beat the analysts' financial forecasts?
Based on DENTSPLY SIRONA's last annual report (Dec 2022), the company's revenue was $3.92B, which missed the average analysts forecast of $3.95B by -0.78%. Apple's EBITDA was $634M, missing the average prediction of $811.94M by -21.92%. The company's net income was $-950M, missing the average estimation of $351.7M by -370.12%. Apple's SG&A was $1.59B, beating the average forecast of $1.57B by 1.41%. Lastly, the company's EPS was $-4.41, missing the average prediction of $1.96 by -325.24%. In terms of the last quarterly report (Sep 2023), DENTSPLY SIRONA's revenue was $947M, missing the average analysts' forecast of $975.21M by -2.89%. The company's EBITDA was $77M, missing the average prediction of $195.9M by -60.69%. DENTSPLY SIRONA's net income was $-266M, missing the average estimation of $99.48M by -367.39%. The company's SG&A was $372M, missing the average forecast of $396.56M by -6.19%. Lastly, the company's EPS was $-1.26, missing the average prediction of $0.484 by -360.41%